children with ALL than in controls (Sutton, Bishun, and Soothill, 1969) . These results have since been confirmed (Chandra, 1972; Hie-Won et al., 1973) . Apart from showing infection in the leukaemic children, there were other reasons for suspecting that the EB virus might be associated with this immunological abnormality. The EB virus is associated with malignant disease and with IM; patients with IM have high levels of IgM (Wollheim and Williams, 1966; Sutton et al., 1973) , produce autoantibodies, including antibodies to smooth muscle (Holborow, Hemsted, and Mead, 1973; Sutton et al., 1974c) which have also been observed in malignant disease (Whitehouse and Holborow, 1971) , and may have temporary impairment of cell-mediated immunity (Haider et al., 1973) , of possible significance in oncogenesis (Keast, 1970) ; following IM there is an increased risk of developing malignant lymphomata and, rarely, IM may be followed by leukaemia (Connelly and Christine, 1974; Levine et al., 1972) .
These observations prompted a search for evidence of EB virus infection in relatives of children with ALL. We used a method which differed completely from that used in our earlier work and which was intended to investigate the nature of the raised IgM levels in the mothers. Small volumes of sera and lack of adequate controls prevented us from testing sera from the index cases. Patients with confirmed IM were used as positive controls.
Materials and methods
The sources of sera from patients with IM, from relatives of leukaemic children, and from controls have been described previously (Sutton et al., 1969 (Sutton et al., , 1971 .
Sera from 2 apparently healthy mothers of children attending hospital were also included as controls.
All sera were separated within 24-48 hours of collection and stored for varying periods at -70°C or -20°C, without preservative; control and test sera were treated identically.
IgM and IgG fractions were obtained by chromatographic separation on G-200 Sephadex and their identities confirmed by radial immunodiffusion against monospecific antisera. The fractions were pooled by immunoglobulin class and concentrated by ultrafiltration, using an 'Amicon' cell, to about 4 times their initial volume. They were then tested by indirect immunofluorescence (Nikoskelainen, 1973) . Antibodies to EB virussoluble CF antigen were assayed by methods described previously (Sutton et al., 1971) (Seigel, 1956) The prevalence of IgM antibodies was thus greater in patients with IM than in controls (P = 0 0031).
First-degree relatives of children with ALL. EB-virus-specific IgM and IgG antibodies were estimated in 16 mothers and 4 sibs of children with ALL. They were also estimated in 6 healthy mothers of healthy children and in 2 mothers of children attending the same hospital as the patients (Table II) . These sera were comparable with regard to age and parity of donor and to length of storage. The mothers of the leukaemic children had a mean age of 33 5 years and a mean of 2 1 children, and their sera had been stored for a mean period of 79 *6 months. The control mothers had a mean age of 37 0 years, a mean of 2-45 children, and their sera had been stored for a mean period of 74 9 months. There were no controls for the sibs of the leukaemic children (aged 9 months, 1 year, 9 years, and 15 years).
Twelve of the 16 mothers of children with ALL had EB-virus-specific IgM VCA antibodies; 15 had IgG VCA antibodies. All had detectable IgG CF antibody and none had IgM CF antibody. Evans, Niedermann, and McCollum, 1968) , and not in those with rubella or other infections is therefore not surprising and confirms the reliability of our methods. Their persistence in patients tested long after apparent recovery was not entirely unexpected, for total IgM levels in these patients may remain raised for up to 2 years after apparent recovery and virus may be excreted orally for several months (Miller, Niedermann, and Andrews, 1973; Golden et al., 1973) . These raised total IgM levels were not associated with persistence of autoantibodies (such as those to smooth muscle) which are frequently found in patients with IM (Sutton et al., 1974c) . Incidentally, EB-virus-specific IgG antibody was present, in one patient, 15 days after onset and IgM antibody developed later; this gives credence to the suggestion of Stevens, Pry, and Manaker (1970) that IM may not always be a primary infection with EB virus.
EB-virus-specific IgM antibodies were present in more mothers of children with ALL than in controls and were also present in 3 of 4 sibs of the leukaemic children, suggesting active antigenic stimulation with the EB virus in these families. These findings may represent an abnormal host response or they may be more directly related to the leukaemic process.
Infection with EB virus, possibly via blood transfusion (Gerber et al., 1969) , is well recognized during the course of ALL (Lampkin, Canales, and Mauer, 1967; Ragab and Vietti, 1969; Deardorff, Gerber, and Vogler, 1970; Stevens et al., 1971 ) and the possibility of maternal infection from their children cannot be discounted. Nevertheless, many children with newly diagnosed leukaemia have evidence of prior infection (Sutton et al., 1974b) There are other possible mechanisms (Sutton et al., 1974b ; Zorbala-Mallios and Sutton, 1974) whereby EB virus could promote the onset of leukaemia. Apart from these, we consider that the presence of EB-virus-specific IgM antibody in the mothers of children with ALL could explain the raised levels of total IgM found in these women and is compatible with previous infection with this virus in the index cases. The different approaches and techniques strengthen our conclusion that EB virus infection is associated in some way with ALL; there is reason to suppose that this association may be more than fortuitous. 
